An OMRF scientist has received a four-year federal grant to investigate the biological process of cell death.
The grant, awarded by the National Heart, Lung, and Blood Institute, will provide $1.74 million to OMRF scientist Courtney Griffin, Ph.D., to study what triggers a form of cell death called necroptosis in the vascular system. The body uses programmed cell death to carry out specific biological purposes, and Griffin is interested in identifying the causes and effects of necroptosis in blood vessels.
Oklahoma City is home to the Oklahoma Medical Research Foundation, one of the nation’s oldest and most respected nonprofit biomedical research institutes. The organization employs more than 500 people from around the world and annually secures more than $30 million in competitive grants – ranking it in the top 15 of the Association of Independent Research Institutes. Since its inception, OMRF and its labs have produced three FDA-approved drugs, more than 600 U.S. and international patents and several biotechnology spin-off companies.
These sample images are available for download in high resolution .jpg format by registering and logging in. They are intended to be used for editorial purposes only.